Bill Cassidy (R-LA)

Small Biotech Innovation Act

S. 1930 · Senate bill Health

A Republican bill with 1 Republican cosponsor · See the cosponsor

Last activity — Read twice and referred to the Committee on Finance.

In committee

Introduced and handed to a committee in the chamber it started in.

The committee holds it, and most bills are never heard from again. A hearing or a committee vote would be news; silence is the usual outcome, and it kills the bill without anyone voting against it.

Its path through Congress

  1. Introduced
  2. In Committee

What this bill would do

The Small Biotech Innovation Act aims to amend the Social Security Act regarding the Medicare drug price negotiation program. It seeks to create an exception for certain drug manufacturers starting in the year 2029. This exception applies to research and development-intensive small biotech manufacturers. To qualify, these manufacturers must meet specific revenue investment thresholds and drug count criteria. The bill also outlines rules for when a company is acquired by a different manufacturer.

Yes

  • Scored +6

    Does this make it easier to run a small business?

    The bill provides a significant regulatory exception specifically designed to benefit small biotech manufacturers.

  • Scored +5

    Would business owners be better off under this?

    Small biotech business owners benefit from the new exemption from price negotiations.

  • Scored +3

    Does this put more money into medical research?

    The exception may incentivize more R&D investment by small biotech firms.

The opposite· 3 of 6

  • Scored -4

    Does this lower the price of prescription medicines?

    By exempting specific drugs from negotiation, the bill may prevent price reductions that would otherwise lower drug costs.

  • Scored -3

    Does this reduce what the federal government spends?

    By exempting certain drugs from price negotiation, the bill may increase Medicare drug spending compared to the baseline.

  • Scored -2

    Would people over 65 be better off under this?

    Seniors on Medicare may face higher drug costs because certain drugs are exempt from price negotiations.